alnuctamab
bms
['alnuctamab']
dr sandy wong presenting alnuctamab results ; sub q dosing showed higher response rates and expected safety 
Interim Chief Hematology, Director- Blood and Marrow Transplant, Co-Director Myeloma Program - Part-time Skier